Logo for Harmony Biosciences Holdings Inc

Harmony Biosciences Investor Relations Material

Latest events

Logo for Harmony Biosciences Holdings Inc

Q4 2023

Harmony Biosciences
Logo for Harmony Biosciences

Q4 2023

22 Feb, 2024
Logo for Harmony Biosciences

Q3 2023

31 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Harmony Biosciences Holdings Inc

Access all reports
Harmony Biosciences Holdings, Inc. is a commercial-stage pharmaceutical company that develops and sells novel therapies for people with rare diseases. It offers Naurex, an investigational drug to treat depression; Wakix, an oral treatment for excessive sleepiness; SPRITAM rapidly disintegrated tablets to treat nighttime seizures; and EVKOTEBO for prevention of recurrent seizures in people with partial-onset epilepsy. The company was formerly known as Axsome Therapeutics, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in January 2019. Harmony Biosciences Holdings, Inc. was founded in 2017and is headquartered in Plymouth Meeting, Pennsylvania.